Cite
HARVARD Citation
Fogelman, D. et al. (2014). Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?. Journal of cachexia, sarcopenia and muscle. 5 (4), pp. 307-313. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fogelman, D. et al. (2014). Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?. Journal of cachexia, sarcopenia and muscle. 5 (4), pp. 307-313. [Online].